Orscan Technologies reportedly is planning to launch an initial public offering although the amount that it hopes to raise is not yet disclosed. The Israeli company has developed, among other things, the Skin-Vision 3D imaging device that uses mole mapping to help diagnose melanoma early.

Full Story:
Globes (Israel)

Related Summaries